Two Sigma Advisers’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Two Sigma Advisers’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,700	Closed	-$2.58K	–	2809
2022 Q4	$2.58K	Sell	15,700 -187,200	-92%	-$78.4K	﹤0.01%	2490
2022 Q3	$132K	Sell	202,900 -87,700	-30%	-$129K	﹤0.01%	2269
2022 Q2	$706K	Sell	290,600 -102,900	-26%	-$286K	﹤0.01%	1770
2022 Q1	$1.59M	Sell	393,500 -73,700	-16%	-$404K	﹤0.01%	1383
2021 Q4	$3.74M	Buy	467,200 +79,300	+20%	+$930K	0.01%	900
2021 Q3	$7.49M	Buy	387,900 +121,300	+45%	+$2.12M	0.02%	607
2021 Q2	$3.68M	Buy	266,600 +188,900	+243%	+$2.24M	0.01%	1011
2021 Q1	$702K	Buy	+77,700	New	+$568K	﹤0.01%	1851

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Two Sigma Advisers's PLXP Position: Q1 2023 in Review

Two Sigma Advisers sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2023, closing a stake of 15,700 shares — an estimated $2.58K sold.

Two Sigma Advisers first reported a position in PLXP in Q1 2021 and held it in 8 quarters. The position peaked at $7.49M in Q3 2021. 34 funds tracked by Wall St. Rank hold PLXP as of Q1 2023.

Two Sigma Advisers reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Two Sigma Advisers sold 15,700 PLx Pharma Inc. Common Stock shares in Q1 2023, an estimated $2.58K.
Two Sigma Advisers first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Two Sigma Advisers's PLx Pharma Inc. Common Stock position peaked at $7.49M in Q3 2021.
34 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.